Chuck Ence

RLMD

Chuck Ence serves as CAO and COO at Relmada Therapeutics, Inc. (RLMD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$553.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$553.5K

Companies Traded

RLMD

Active Period

Jan 2024 – Nov 2025

3 total trades

Most Recent

Buy RLMD

Nov 5, 2025 · $299.2K

Chuck Ence's Insider Trading at Relmada Therapeutics, Inc. (RLMD)

Buys

3 · $553.5K

Sells

0 · $0.00

Total Shares Bought

403,931

Total Shares Sold

RLMD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 5, 2025	Buy	136,000	$2.20	$299.2K	0
May 16, 2025	Buy	228,961	$0.45	$103.3K	0
Jan 31, 2024	Buy	38,970	$3.87	$150.9K	38,970

Related Insiders

Maged Shenouda

officer: Chief Financial Officer

RLMDBuy · Sep 11, 2026

TRAVERSA SERGIO

director, officer: Chief Executive Officer

RLMDBuy · Sep 11, 2026

Paul Edward Kelly

Chief Operating Officer

RLMDBuy · Nov 5, 2025

Explore More Insider Trading Data

RLMD Insider Trading Activity

View all insider trades at Relmada Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity